Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2014 1
2015 3
2016 4
2017 3
2018 3
2019 6
2020 9
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE, Homs MYV, Grünhagen DJ, Filipe WF, Bennink RJ, Besselink MGH, Borel Rinkes IHM, Bruijnen RCG, Cercek A, D'Angelica MI, van Delden OM, Donswijk ML, van Doorn L, Doornebosch PG, Emmering J, Erdmann JI, IJzerman NS, Grootscholten C, Hagendoorn J, Kemeny NE, Kingham TP, Klompenhouwer EG, Kok NFM, Koolen S, Kuhlmann KFD, Kuiper MC, Lam MGE, Mathijssen RHJ, Moelker A, Oomen-de Hoop E, Punt CJA, Te Riele WW, Roodhart JML, Swijnenburg RJ, Prevoo W, Tanis PJ, Vermaas M, Versleijen MWJ, Veuger FP, Weterman MJ, Verhoef C, Groot Koerkamp B. Buisman FE, et al. Among authors: bruijnen rcg. BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6. BMC Cancer. 2019. PMID: 30953467 Free PMC article.
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study.
Braat AJAT, Bruijnen RCG, van Rooij R, Braat MNGJA, Wessels FJ, van Leeuwaarde RS, van Treijen MJC, de Herder WW, Hofland J, Tesselaar MET, de Jong HWAM, Lam MGEH. Braat AJAT, et al. Among authors: bruijnen rcg. Lancet Oncol. 2020 Apr;21(4):561-570. doi: 10.1016/S1470-2045(20)30027-9. Epub 2020 Feb 26. Lancet Oncol. 2020. PMID: 32112737 Clinical Trial.
Current Status and Future Direction of Hepatic Radioembolisation.
Alsultan AA, Braat AJAT, Smits MLJ, Barentsz MW, Bastiaannet R, Bruijnen RCG, de Keizer B, de Jong HWAM, Lam MGEH, Maccauro M, Chiesa C. Alsultan AA, et al. Among authors: bruijnen rcg. Clin Oncol (R Coll Radiol). 2021 Feb;33(2):106-116. doi: 10.1016/j.clon.2020.12.003. Epub 2020 Dec 24. Clin Oncol (R Coll Radiol). 2021. PMID: 33358630 Free article.
Dose-Effect Relationships of 166Ho Radioembolization in Colorectal Cancer.
van Roekel C, Bastiaannet R, Smits MLJ, Bruijnen RC, Braat AJAT, de Jong HWAM, Elias SG, Lam MGEH. van Roekel C, et al. Among authors: bruijnen rc. J Nucl Med. 2021 Feb;62(2):272-279. doi: 10.2967/jnumed.120.243832. Epub 2020 Jun 26. J Nucl Med. 2021. PMID: 32591491
Radioembolisation in Europe: A Survey Amongst CIRSE Members.
Reinders MTM, Mees E, Powerski MJ, Bruijnen RCG, van den Bosch MAAJ, Lam MGEH, Smits MLJ. Reinders MTM, et al. Among authors: bruijnen rcg. Cardiovasc Intervent Radiol. 2018 Oct;41(10):1579-1589. doi: 10.1007/s00270-018-1982-4. Epub 2018 May 8. Cardiovasc Intervent Radiol. 2018. PMID: 29740687 Free PMC article.
Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization-a prospective, within-patient randomized study.
van Roekel C, van den Hoven AF, Bastiaannet R, Bruijnen RCG, Braat AJAT, de Keizer B, Lam MGEH, Smits MLJ. van Roekel C, et al. Among authors: bruijnen rcg. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1658-1668. doi: 10.1007/s00259-020-05079-0. Epub 2020 Oct 31. Eur J Nucl Med Mol Imaging. 2021. PMID: 33128132 Free PMC article.
Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study.
Fegrachi S, Walma MS, de Vries JJJ, van Santvoort HC, Besselink MG, von Asmuth EG, van Leeuwen MS, Borel Rinkes IH, Bruijnen RC, de Hingh IH, Klaase JM, Molenaar IQ, van Hillegersberg R. Fegrachi S, et al. Among authors: bruijnen rc. Eur J Surg Oncol. 2019 Nov;45(11):2166-2172. doi: 10.1016/j.ejso.2019.06.008. Epub 2019 Jun 12. Eur J Surg Oncol. 2019. PMID: 31227340 Clinical Trial.
Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort.
Walma MS, Brada LJ, Patuleia SIS, Blomjous JG, Bollen TL, Bosscha K, Bruijnen RC, Busch OR, Creemers GJ, Daams F, van Dam R, Festen S, Jan de Groot D, Willem de Groot J, Mohammad NH, Hermans JJ, de Hingh IH, Kerver ED, van Leeuwen MS, van der Leij C, Liem MS, van Lienden KP, Los M, de Meijer VE, Meijerink MR, Mekenkamp LJ, Nederend J, Nio CY, Patijn GA, Polée MB, Pruijt JF, Renken NS, Rombouts SJ, Schouten TJ, Stommel MWJ, Verweij ME, de Vos-Geelen J, de Vries JJJ, Vulink A, Wessels FJ, Wilmink JW, van Santvoort HC, Besselink MG, Molenaar IQ; Dutch Pancreatic Cancer Group. Walma MS, et al. Among authors: bruijnen rc. Eur J Surg Oncol. 2021 Mar;47(3 Pt B):699-707. doi: 10.1016/j.ejso.2020.11.137. Epub 2020 Nov 26. Eur J Surg Oncol. 2021. PMID: 33280952 Free article.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page